Correction to: Comparison of the Amplification Refractory Mutation System, Super Amplification Refractory Mutation System, and Droplet Digital PCR for T790 M Mutation Detection in Non-small Cell Lung Cancer after Failure of Tyrosine Kinase Inhibitor Treatment.

Autor: Zhu L; Department of Oncology, Hangzhou Cancer Hospital, Hangzhou, China.; Department of Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Nanjing, China., Zhang S; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Nanjing, China. shirley4444@gmail.com., Xun Y; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Nanjing, China., Jiang Y; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Nanjing, China., Xia B; Department of Oncology, Hangzhou Cancer Hospital, Hangzhou, China., Chen X; Department of Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Nanjing, China., Wang L; Department of Respiratory, Hangzhou First People's Hospital, Nanjing Medical University, Nanjing, China., Jiang H; Department of thoracic surgery, Hangzhou First People's Hospital, Nanjing Medical University, Nanjing, China., Ma S; Department of Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Nanjing, China. mashenglin@medmail.com.cn.
Jazyk: angličtina
Zdroj: Pathology oncology research : POR [Pathol Oncol Res] 2018 Oct; Vol. 24 (4), pp. 951.
DOI: 10.1007/s12253-018-0421-9
Abstrakt: The affiliation of first author (Lucheng Zhu) should be Department of Oncology, Hangzhou Cancer Hospital and Department of Oncology, Hangzhou First People's Hospital, Nanjing Medical University.
Databáze: MEDLINE
Externí odkaz: